Skip to main content
User menu
Subscribe
Donate
The HIV Treatment Journal of
Webinars
Current Issue
Drug Guides
Trending
COVID-19 and HIV
HIV Decriminalization
Hepatitis C
U=U
HIV & Aging
HIV Basics
HIV Cure Research
HIV Prevention
HIV Treatment
Stigma & Discrimination
POZ Advocate
Archive
About
Who We Are
Advertise
Contact
Subscribe
Reader/Customer Service
News
Donate
Donate
Bulk Subscriber Donation
Search
10 Years of the U=U campaign: Where it’s succeeded—and fallen short
Being Bridgette: Community and clinicians meet
Biktarvy is among the 15 drugs facing Medicare price negotiations
Back to top
Search
First Person: When Brandon met Jasmine
10 Years of the U=U campaign: Where it’s succeeded—and fallen short
Biktarvy is among the 15 drugs facing Medicare price negotiations
Briefly: Mar + Apr 2026
Editor’s Note Mar + Apr 2026
Surviving AIDS, now aging with HIV
FDA approves a new once-daily, two-drug combo for HIV treatment
When fear disrupts HIV care
ViiV moves to expand Dovato use into pediatric HIV care
Safe by science, criminalized by law
Pagination
First page
« First
Previous page
‹‹
…
Page
5
Current page
6
Page
7
Page
8
…
Next page
››
Last page
Last »
